Skip to main content
OpenTrials
Completed

NCT Number: NCT03796520

Validation Study of the Simplified Seizure Classification Algorithm

An algorithm has been developed for simplified classification of epileptic seizures, in order to optimize choice of antiepileptic drugs.

The objective of this study was to clinically validate the algorithm.

Completed

Looking for future studies?

Notify Me

Key information

Age range

10 year–120 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Aarhus University Hospital, Aarhus, Denmark

Loading trial locations.

About this study

Optimal choice of antiepileptic drugs (AEDs) depend on the patients´ seizure-types. Over the last four decades, several classification systems have been proposed for epileptic seizures. The recent position paper of the International League Against Epilepsy defines 63 seizure-types. While this complex system might be useful for detailed phenotyping, currently there is no evidence that each of these seizure-types needs different clinical management strategy, and many clinicians find it difficult to implement.

To help physicians with optimizing the choice of AEDs, the investigators developed a simplified seizure classification, consisting of the minimal number of seizure-types, necessary for choice of AEDs, and the investigators developed an algorithm that identifies the patient´s seizure-type, based on a set of 10 simple questions, that can be answered by physicians even without extensive training in epilepsy. The current form of the algorithm was developed for patients whose seizures started in adolescence or adulthood (at the age of 10 years or older).

In this study, the investigators aim to validate the diagnostic algorithm, by comparing the seizure-type identified by the algorithm with the diagnosis and seizure-type as defined by trained experts, in the clinical workup of the patients.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients referred to the participating centers on suspicion of epilepsy

Exclusion criteria

  • none

Treatment and study plan

EpiPick simplified seizure classification algorithm

Diagnostic Test

EpiPick simplified seizure classification algorithm input:

Grey matter brain lesion Exclusively nocturnal seizures First seizure at age > 20 years Lip smacking or chewing during seizures Staring with impaired awareness, lasting less than 20s without postictal confusion Sudden irregular jerks, in isolation or brief series, if none of the following applies: Are the jerks consistently in the same limb? When resting in bed when falling asleep? Bilateral tonic-clonic seizures within 1h of awakening or immediately preceded by irregular jerks Any of the following is present: Skin turning pale pre-ictally; Loss of consciousness immediately after urination or defecation; Sudden slump with loss of awareness, lasting less than 10 seconds; Seizure lasting longer than 10 minutes, with eyes closed throughout the seizure; Severe pre-ictal headache; Episodes consisting of falls that occur always after change in posture to the upright position, or coughing or feeling pain.

Primary outcomes

  1. AC1

    Time frame: Through study completion, an average of 8 months.

    Agreement coefficient between index test (EpiPick) and the reference standard (expert classification)

Sponsors and collaborators

Lead sponsor

Sándor Beniczky

Other

Collaborators

  • Danish Epilepsy Centre
  • Shiraz University of Medical Sciences
  • Thomas Jefferson University
  • University of Pavia

Registry information

Official study title

Clinical Validation Study of the Simplified Seizure Classification Algorithm

Acronym: VASSCA

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Jan 8, 2019
Registry last updated
Feb 17, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.